𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Spermine prevents cytochrome c release in glucocorticoid-induced apoptosis in mouse thymocytes

✍ Scribed by Cecilia Hegardt; Gunnar Andersson; Stina M Oredsson


Book ID
104375231
Publisher
Elsevier Science
Year
2003
Tongue
English
Weight
185 KB
Volume
27
Category
Article
ISSN
1065-6995

No coin nor oath required. For personal study only.

✦ Synopsis


Abstract

Apoptosis can be induced in primary cultures of mouse thymocytes using the glucocorticoid dexamethasone. Addition of the polyamine spermine simultaneously with dexamethasone reduces the induction of apoptosis compared to treatment with dexamethasone alone. We investigated the signal transduction pathway at the mitochondrial level in order to elucidate spermine's protective effect. Mitochondrial involvement is evident due to the loss of mitochondrial transmembrane potential, release of cytochrome c into the cytosol and activation of caspase‐9 in dexamethasone‐treated thymocytes. The addition of spermine inhibited the release of cytochrome c from the mitochondria into the cytosol, and also the activation of caspase‐9. When the mitogen concanavalin A (Con A) was added to dexamethasone‐ plus spermine‐treated thymocytes, the number of apoptotic cells in the pre‐G~1~peak was reduced compared to thymocytes treated with only dexamethasone plus spermine. Comparing concanavalin A added to dexamethasone‐treated or to dexamethasone plus spermine‐treated thymocytes, showed a markedly reduced pre‐G~1~peak in the latter. Thus, the spermine‐induced inhibition of cytochrome c release confers a survival advantage on thymocytes.


📜 SIMILAR VOLUMES


Betulin induces mitochondrial cytochrome
✍ Yang Li; Kan He; Yinghui Huang; Daxin Zheng; Chang Gao; Lin Cui; Ying-Hua Jin 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 619 KB

## Abstract We examined whether betulin, a naturally abundant compound, has anticancer functions in human cancer cells. The results showed that betulin significantly inhibited cell viability in cervix carcinoma HeLa cells, hepatoma HepG2 cells, lung adenocarcinoma A549 cells, and breast cancer MCF‐